Evidence map›Paper›PMID 40352212›Full record

ArticleNarra J2025

Computational drug repurposing for tuberculosis by inhibiting Ag85 complex proteins.

Israini W Iskandar, Astutiati Nurhasanah, Mohammad Hatta, Firdaus Hamid, Irda Handayani, Ummi Chaera, Andi A Yusriyyah, Balqis D Jamaluddin, St Zaenab, Najdah Hidayah and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Narra J, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Antigen 85B ofVaccines · 2026
    Review
  2. Antimicrobial Resistance: The Answers.British journal of biomedical science · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Israini W IskandarMaster Program of Biomedical Science, Postgraduate School, Universitas Hasanuddin, Makassar, Indonesia.
Astutiati NurhasanahResearch and Innovation Agency (BRIN), Banten, Indonesia.
Mohammad HattaDepartment of Clinical Microbiology, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia.
Firdaus HamidDepartment of Clinical Microbiology, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia.
Irda HandayaniDepartment of Clinical Pathology, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia.
Ummi ChaeraMaster Program of Biomedical Science, Postgraduate School, Universitas Hasanuddin, Makassar, Indonesia.
Andi A YusriyyahDepartment of Marine Science, Faculty of Marine Science and Fisheries, Universitas Hasanuddin, Makassar, Indonesia.
Balqis D JamaluddinMaster Program of Biomedical Science, Postgraduate School, Universitas Hasanuddin, Makassar, Indonesia.
St ZaenabUniversitas Cokroaminoto Makassar, Makassar, Indonesia.
Najdah HidayahGraduate School of Biomedical Sciences, Universitas Hasanuddin, Makassar, Indonesia.
Nihayatul KarimahResearch and Innovation Agency (BRIN), Banten, Indonesia.
Andi D PermanaFaculty of Pharmacy, Universitas Hasanuddin, Makassar, Indonesia.
Muhammad N MassiDepartment of Clinical Microbiology, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) remains a significant and deadly infection among pulmonary diseases caused by

Indexed as

AcyltransferasesAntigens, BacterialAntitubercular AgentsBacterial ProteinsDrug RepositioningMycobacterium tuberculosisTuberculosisHumansMolecular Docking SimulationMolecular Dynamics SimulationAcyltransferasesantigen 85A, Mycobacterium tuberculosisAntigens, BacterialAntitubercular AgentsBacterial ProteinsAg85 complex proteinsdrug-repurposedmolecular dockingmolecular dynamicstuberculosis

Identifiers

PMID40352212
PMCPMC12059857

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.